15-62067675-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_207322.3(C2CD4A):c.62T>C(p.Leu21Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000144 in 1,455,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_207322.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD2 exomes  AF:  0.0000167  AC: 4AN: 239380 AF XY:  0.0000228   show subpopulations 
GnomAD4 exome  AF:  0.0000144  AC: 21AN: 1455248Hom.:  0  Cov.: 31 AF XY:  0.0000179  AC XY: 13AN XY: 724248 show subpopulations 
Age Distribution
GnomAD4 genome  
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
The c.62T>C (p.L21P) alteration is located in exon 2 (coding exon 1) of the C2CD4A gene. This alteration results from a T to C substitution at nucleotide position 62, causing the leucine (L) at amino acid position 21 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at